search this site.

130430P - DATA MANAGEMENT: ETHICO-LEGAL CONSIDERATIONS (Word Slides)

Print Friendly and PDFPrint Friendly

Presentation at the Workshop on Data Management held at King Saud University Riyad Saudi Arabia on April 30, 2013 by Professor Omar Hasan Kasule Sr. MB ChB (MUK), MPH (Harvard), DrPH (Harvard) Chairman Institutional Review Board and Department of Bioethics King Fahad Medical City Riyadh EM: omarkasule@yahoo.com


INTRODUCTION
·         Data includes words, numbers, images, and voice most often in an electronic form.
·         Modern information technology handling large and multiple datasets has spawned new ethical issues that researchers dealing with a single research data base in one institution did not face. These issues are: data costs, data ownership, data confidentiality, and patient safety based on data validity.
·         These ethical issues arise at the stages of data sourcing / collection, data editing, and data storage and retrieval.
·         They also arise in the processes of data sharing and data integration.

USES OF EXISTING DATA SOURCES
·         Data from existing data sources for clinical epidemiology[1],[2]
·         Use of existing data bases for morbidity information: injury[3],[4], chronic conditions[5],
·         Use of existing data to analyze policy[6]
·         Use of existing data for research on specific conditions: heart failure,[7] diabetes[8] [9] [10], HIV[11], asthma[12], knee arthroplasty[13]
·         Genome data interpretation using internet and public data bases[14]
·         Others: herbal medicine[15], drug safety[16]

QUALITY ISSUES OF EXISTING DATA SOURCES
·         Assessing quality of existing data sources[17]
·         Assessing coverage and completeness of existing data[18]
·         Assessing data sources on occupational fatality[19]
·         Comprehensiveness of data sources[20]
·         Under registration of death in Thailand[21]

ETHICS OF USING EXISTING DATA SOURCES
·         Operational data generated by hospitals, health insurance companies, and administrative units is not collected with due care to ensure research-quality accuracy (accuracy, coverage). The defects of these data bases can be overcome by instituting quality control programs and using multiple sources for cross validation. Is it ethical to have low quality routine operational data that cannot be used for research or valid policy analysis?
·         Operational data lies unused in data banks while researchers apply for and get grants to collect new data for their research purposes. Is it ethical to collect new data when we have a lot of routinely collected data?
·         Ethical issues in genetic data collection from critically ill patients[22]
·         Using human samples for environmental bio-monitoring[23]
·         Data ownership and responsible research[24]. Which researcher has a right to use data in the charts.
·         Trade in data: can we buy data from subjects or from collectors? Can we sell data for research? Sell/trade/purchase?
·         Data ownership?: data from public publications, data in patient charts (epidemiological & clinical analysis), case reports
·         The data can be used for research by permission of the legal owner; laws and regulations are not yet clear on this issue because potential owners include the patients, the physicians, and the institutions.
·         The issue of ownership leads to another question whether routinely collected data can be sold to researchers. A corollary to this is whether researchers can engage in selling or buying data with other researchers or commercial marketing and advertising agencies.

ACCESS TO MORE DATA BY DATA INTEGRATION AND DATA SHARING 1
·         Data integration and data sharing, facilitated by modern information technology, enable access to more data in other institutions for analysis and standard setting.
·         Information technology provides the algorithms for fast integration and sharing.
·         Both integration and sharing are an ethical imperative to advance knowledge that benefits patients.
·         Integration and sharing have been used mostly in genomic sequencing, nuclear mapping, imaging, clinical trials, and organ transplantation research.

DATA INTEGRATION
·         Three levels of integration (within species and interspecies) in plant science to gain different understanding[25]
·         Comparing and integrating data from various sources[26]
·         Algorithm for fast integration of data from various sources[27]
·         Integration of distributed data sources[28]
·         Integration of data from various sources on adverse effects[29]
·         Interoperability and data integration[30]
·         Methodology[31]

DATA SHARING 1
·         Benefits of data sharing: making data sharing count[32], making data sharing work[33], sharing online data among people with epilepsy[34], medical research data sharing: the public good[35]
·         Processes of data sharing: data sharing not simple[36], different practices of data sharing among scientists[37], bottle necks in data sharing[38], data standardization[39]
·         Technology of data sharing: electronic data sharing[40], platform for data sharing[41], cryptographic approach to data sharing[42], informatics to enable data sharing[43], Secure data sharing portals[44]
·         Policies and regulations: Need for data sharing policy[45], Institute wide data sharing policy[46]
·         Examples of data shared: genetic[47], nuclear mapping[48], mass spectrometry[49], neuroimaging[50], neuroimaging data[51], Health care[52], prevention of alcohol related violence[53], Data sharing on lung injury[54], Sharing of clinical trials data[55], Data sharing with e-health[56], Analysis of organ sharing data[57], Sharing autism research data[58]
·         Analysis: Post liver transplant obesity based on analysis of shared data[59], Analysis based on data sharing[60]

ETHICAL ISSUES IN DATA SHARING 1
·         Data sharing: ethical and practical issues[61]
·         Intellectual property, informed consent, privacy, and confidentiality. Codes, standards, policies and mapping at local and international levels are being developed to address these issues.
·         Owners of data collected at great expense are reluctant to share with others without proper acknowledgement of intellectual property.
·         Informed consent from patients is needed for data sharing unless fully anonymised.
·         Data privacy and confidentiality are assured by use of secure data portals and cryptography.

ETHICAL ISSUES IN DATA SHARING 2
·         Sharing HIV data: confidentiality and acceptability[62]
·         Genetic data: benefits vs risks[63], code for sharing international genetic data[64], Consent for data sharing in genomic research[65], risks in sharing aggregate genetic data[66]
·         Intellectual property in data sharing[67]
·         Data sharing vs protection of privacy[68], Privacy compliance in data sharing[69], Preserving privacy with data sharing[70]
·         neuroimaging data[71], Standardization and risks[72], patient control of neuroimaging data[73]
·         Misuse of Data use for dual use[74]

DATA PROCESSING
·         Data processing within one research project has its own ethical issues. The data manager could introduce biases, random or non-random, in the processes of adjusting for missing data, data transformation, and creation of derived variables.
·         Data processing mistakes underlie several types of bias: misclassification, selection bias, and sampling bias. Any mistakes introduced at this stage will impact the final research results and eventually affect patient safety due to clinical interventions based on false research.
·         The usual procedures for data privacy and data confidentiality must be respected. As far as possible personal identifiers should not be accessible except to a few selected members of the research team. The data should be kept locked up or in password protected computers. If the computers are connected online the institution should have policies and software to assure data security.

DATA EDITING AND VALIDATION
·         Data editing can lead to biases that will eventually impact on patient safety through wrong research data and conclusions.
·         Potential biases in dealing with missing data
·         Sampling biases
·         Biases in data transformation: qualitative vs quantitative, ordinal vs nominal, continuous vs discrete, creating new variables by combining variables or by mathematical transformations

DATA VALIDATION
·         Cross validation using multiple sources[75],[76],[77],[78],[79],[80],[81]
·         Inconsistencies between administrative and clinical data[82] requires validation by examination[83],[84]
·         Difference in 2 national data bases on mental health[85]
·         Capture-recapture using different sources on adverse effects[86]

CONFIDENTIALITY:
·         Disclosure
·         Sharing


REFERENCES




[1]  Epidemiol. 2013;5:81-8.
[2] Clin Epidemiol. 2012;4:303-13.
[3] Acad Emerg Med. 2012 Apr;19(4):469-80.
[4] Traffic Inj Prev. 2012;13 Suppl 1:57-63.
[5] BMC Public Health. 2011 Sep 5;11:688..
[6] Public Health Rep. 2011 Sep-Oct;126 Suppl 3:127-34.
[7] Heart Fail Clin. 2013 Jan;9(1):1-13.
[8] Clin Epidemiol. 2012;4(Suppl 1):15-9..
[9] Diabetes Care. 2011 Nov;34(11):2387-9..
[10] Exp Clin Endocrinol Diabetes. 2012 Jul;120(7):410-5.
[11] AIDS. 2012 Sep 10;26(14):1829-34..
[12] Pediatr Pulmonol. 2012 Mar;47(3):211-9..
[13] Clin Epidemiol. 2012;4:125-35
[14] Hum Mutat. 2012 Feb 14..
[15] J Ethnopharmacol. 2012 Apr 10;140(3):526-34..
[16] Pharmacoepidemiol Drug Saf. 2012 Jan;21(1):21-33..
[17] Traffic Inj Prev. 2013;14(3):267-73..
[18] Asian Pac J Cancer Prev. 2012;13(8):3617-9.
[19] Am J Ind Med. 2012 Apr;55(4):332-43.
[20] J R Soc Med. 2012 Jun;105(6):250-62..
[21] Bull World Health Organ. 2011 Nov 1;89(11):806-12..
[22] Pharmacogenomics J. 2010 Apr;10(2):77-85..
[23] Environ Health. 2008 Jun 5;7 Suppl 1:S13..
[24] J Speech Lang Hear Res. 2011 Feb;54(1):S330-45..
[25] Stud Hist Philos Biol Biomed Sci. 2013 Apr 6. pii: S1369-8486(13)00034-4
[26] Stat Med. 2012 Dec 10;31(28):3748-59..
[27] BMC Med Inform Decis Mak. 2012 Jun 28;12:59..
[28] J Clin Bioinforma. 2011 Nov 21;1:32..
[29]Clin Pharmacol Ther. 2011 Nov;90(5):645-6..
[31] Med Teach. 2013;35(3):e1011-9.
[32] Front Neurosci. 2013;7:9.
[33] Neuroimage. 2012 Oct 30. pii: S1053-8119(12)01067-1..
[34] Epilepsy Behav. 2012 Jan;23(1):16-23..
[35] Med Law Rev. 2012 Sep;20(4):516-39..
[36] Environ Health. 2011 Dec 21;10:107
[37] PLoS One. 2011;6(6):e21101.
[38] Hum Mutat. 2012 Oct;33(10):1494-6..
[39] Biochim Biophys Acta. 2013 Mar 20. pii: S1570-9639(13)00124-6..
[40] Curr Oncol Rep. 2012 Dec;14(6):486-93..
[41] Euro Surveill. 2013 Jan 24;18(4):20387..
[42] J Am Med Inform Assoc. 2013 Jan 1;20(1):69-76.
[43] Magn Reson Imaging. 2012 Nov;30(9):1249-56.
[44] Philos Transact A Math Phys Eng Sci. 2012 Dec 10;371(1983):20120069
[45] Top Cogn Sci. 2013 Jan;5(1):214-21..
[46] Genome Med. 2011 Sep 28;3(9):60..
[47] PLoS One. 2012;7(6):e37552..
[48] RNA. 2011 Jul;17(7):1204-12.
[49] J Proteomics. 2012 Aug 30;75(16):5111-2..
[51] Neuroimage. 2013 Mar 4. pii: S1053-8119(13)00174-2..
[52] Value Health. 2012 Jan-Feb;15(1 Suppl):S132-8.
[53] Inj Prev. 2012 Oct;18(5):315-20.
[54] Respir Care. 2011 Sep;56(9):1258-68; discussion 1268-72..
[55]BMJ. 2012 Nov 20;345:e7570.
[57] J Pediatr. 2013 Feb;162(2):313-8.e1..
[58] Neuroinformatics. 2012 Oct;10(4):331-9.
[59] Pediatr Transplant. 2012 Feb;16(1):41-9..
[60] Genet Epidemiol. 2012 Apr;36(3):263-73.
[61] Genome Res. 2011 Jul;21(7):1001-7..

[62] Implement Sci. 2012 Apr 19;7:34..

[63] Public Health Genomics. 2012;15(2):106-14..
[64] Genome Med. 2011 Jul 14;3(7):46
[65] Genet Med. 2011 Nov;13(11):948-55..
[66] Nat Rev Genet. 2011 Sep 16;12(10):730-6..
[69] Methods Inf Med. 2011;50(4):326-36..
[71] Neuroimage. 2013 Mar 4. pii: S1053-8119(13)00174-2..
[72] BMC Res Notes. 2011 Sep 9;4:349.
[73] J Am Med Inform Assoc. 2013 Jan 1;20(1):157-63..
[74] Sci Eng Ethics. 2013 Mar;19(1):83-92.
[75] BMC Med Res Methodol. 2013 Feb 11;13:17..
[76] Int J Health Geogr. 2013 Jan 17;12:2. '.
[77] Occup Med (Lond). 2013 Jan;63(1):30-7
[78] BMC Public Health. 2012 Jun 18;12:443..
[79] Int J Technol Assess Health Care. 2012 Apr;28(2):133-7..
[80] J Registry Manag. 2011 Spring;38(1):30-8..
[81] Occup Environ Med. 2012 May;69(5):317-24..
[82] J Am Coll Surg. 2012 May;214(5):798-805..
[83] BMC Health Serv Res. 2012 Oct 13;12:358..
[84] BMC Med Res Methodol. 2012 Jul 11;12:97.
[85] Can J Psychiatry. 2012 Jun;57(6):366-74..
[86] Aust N Z J Public Health. 2012 Jun;36(3):223-8..